Your source for the production of high-volume recombinant therapeutic proteins in the white of transgenic chicken eggs. An effectively priced alternative that:
|
||||||
Thank you for visiting our website! Any statements contained within this website which are not historical facts, including projections or statements concerning capabilities, plans, results and the expected benefits to be derived there from, are forward looking statements that involve risks and uncertainties as identified in TranXenoGen’s disclosure documents filed with the U.K. Alternative Investment Market of the London Stock Exchange. The Company does not undertake any obligation to update forward looking statements. The Company’s shares have not been registered under the U.S. Securities Act of 1933, as amended (“the Securities Act”) and are “restricted securities” as defined in Rule 144 promulgated under the Securities Act. |
||||||
NEWS CENTER I CAREERS I CONTACT US I DIRECTIONS TRANXENOGEN, INC. • PO BOX 21 • NORTHBORO, MA. 01532 • 508 842 5036 © COPYRIGHT TRANXENOGEN, INC. 2002 |
||||||